Efficacy of α-lipoic acid in diabetic neuropathy

N Papanas, D Ziegler - Expert Opinion on Pharmacotherapy, 2014 - Taylor & Francis
Introduction: Neuropathy is a serious complication of diabetes. Its management focuses on
glycaemic control, multifactorial cardiovascular risk intervention, pathogenesis-oriented …

Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications

F Andrea Moura, K Queiroz de Andrade… - Current Topics in …, 2015 - ingentaconnect.com
Lipoic acid (LA) is an antioxidant able to produce its effects in aqueous or lipophilic
environments. Lipoate is the conjugate base of lipoic acid, and the most prevalent form of LA …

Antioxidant agents for delaying diabetic kidney disease progression: a systematic review and meta-analysis

D Bolignano, V Cernaro, G Gembillo, R Baggetta… - PloS one, 2017 - journals.plos.org
Background Oxidative stress is a key player in the genesis and worsening of diabetic kidney
disease (DKD). We aimed at collecting all available information on possible benefits of …

The role of biofactors in diabetic microvascular complications

D Ziegler, M Porta, N Papanas, M Mota… - Current Diabetes …, 2022 - benthamdirect.com
Microvascular complications are responsible for a major proportion of the burden associated
with diabetes contributing to substantial morbidity, mortality, and healthcare burden in …

[HTML][HTML] Anti-oxidative therapy in diabetic nephropathy

LF Hernandez, N Eguchi, D Whaley… - Frontiers in Bioscience …, 2022 - imrpress.com
Chronic kidney disease is generally progressive and currently has no reliable treatment to
reverse a decline in kidney function or to slow the progression of the disease. Diabetic …

[HTML][HTML] Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy

GJ Dugbartey, KK Alornyo, BB N'guessan… - Biomedicine & …, 2022 - Elsevier
Background Diabetic nephropathy (DN) is the leading cause of end-stage renal disease.
Current pharmacological interventions only retard DN progression. Alpha-lipoic acid (ALA) …

Nitric oxide in the normal kidney and in patients with diabetic nephropathy

P Tessari - Journal of nephrology, 2015 - Springer
Nitric oxide (NO) is a gas with biological and regulatory properties, produced from arginine
by the way of nitric oxide synthases (NOS), and with a very short half-life (few seconds). A …

Receptor for advanced glycation end product, organ crosstalk, and pathomechanism targets for comprehensive molecular therapeutics in diabetic ischemic stroke

NL Rao, GB Kotian, JK Shetty, BP Shelley, MK Dmello… - Biomolecules, 2022 - mdpi.com
Diabetes mellitus, a well-established risk factor for stroke, is related to higher mortality and
poorer outcomes following the stroke event. Advanced glycation end products (AGEs), their …

Effects of antioxidants on diabetic kidney diseases: mechanistic interpretations and clinical assessment

Y Sun, D **, Z Zhang, Y Zhang, Y Zhang, X Kang… - Chinese Medicine, 2023 - Springer
Diabetic kidney disease (DKD) is more prevalent with an increase in diabetes mellitus.
Oxidative stress is a major factor in the occurrence and progression of DKD. Defending …

Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes

MP Valdecantos, PL Prieto-Hontoria, V Pardo… - Free Radical Biology …, 2015 - Elsevier
Excess of saturated free fatty acids, such as palmitic acid (PA), in hepatocytes has been
implicated in nonalcoholic fatty liver disease. α-Lipoic acid (LA) is an antioxidant that …